Shopping Cart
- Remove All
Your shopping cart is currently empty
GB1908 is a selective oral inhibitor of galectin-1 (galectin-1), with Ki values of 57 nM for human galectin-1 and 72 nM for mouse galectin-1. It demonstrates over 50-fold selectivity for galectin-1 compared to galectin-3. GB1908 can be utilized in lung cancer research.

| Description | GB1908 is a selective oral inhibitor of galectin-1 (galectin-1), with Ki values of 57 nM for human galectin-1 and 72 nM for mouse galectin-1. It demonstrates over 50-fold selectivity for galectin-1 compared to galectin-3. GB1908 can be utilized in lung cancer research. |
| Targets&IC50 | Mouse galectin-1:72 nM (Ki), Mouse galectin-3:4200 nM (Ki), Human galectin-1:57 nM (Ki), Human galectin-3:6000 nM (Ki) |
| In vitro | GB1908 (0.1-10 μM; 16 hours) inhibits galectin-1-induced apoptosis in Jurkat cells, with an IC50 of 850 nM. |
| In vivo | Compound GB1908 (Compound 5d; 30 mg/kg; oral administration; twice daily; for 21 days) was shown to reduce the growth of primary lung cancer LL/2 in a syngeneic mouse model. |
| Formula | C18H18Cl2N4O5S2 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.